astrazeneca

Welcome to the 'astrazeneca' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'astrazeneca'.

Are you an expert about 'astrazeneca'? Do you want to be the Technorati authority on 'astrazeneca'? You can write a description that will appear right here: Join Blogcritics!

Latest blogosphere posts tagged “astrazeneca”

 

• AstraZeneca warns of tough year ahead

  
  Business Finance & Economy - business.marc8.com — Authority: 138
  Drug maker AstraZeneca PLC warned of a tough year ahead as it reported a 24 percent increase in 2011 profits.
  11 hours ago

• Unilever loses 3% after City dislikes Marmite makers figures

  
  The Guardian - guardian.co.uk — Authority: 962
  Sales for final quarter disappoint as consumer goods giant remains cautious on outlook Unilever is already facing strikes in protest against changes to its pension scheme, and now the Marmite group is proving unpalatable to the City. Its shares have lost 65p to £20.20 after its final results disappointed and it ...
  12 hours ago

• AstraZeneca to cut 7,300 jobs

  
  The Guardian - guardian.co.uk — Authority: 962
  AstraZeneca said the job cuts, which will cost $2.1bn to implement, would help it save $1.6bn a year by the end of 2014 Drugs company AstraZeneca has announced plans to cut another 7,300 jobs over the next two years. The cuts come on top of 21,600 jobs axed since 2007. The company, which employs 61,000 people ...
  12 hours ago

• AstraZeneca to axe 7,300 jobs over next two years

  
  top99news - breaking news from the world top newspapers — Authority: 164
  http://www.mirror.co.uk/ AstraZeneca to axe 7,300 jobs over next two years Pharmaceuticals giant AstraZeneca is to axe 7,300 jobs by the end of 2014 as part of a fresh round of cost savings. published date:Thu, 02 Feb 2012 07:52:00 GMT
  13 hours ago

• AstraZeneca announces job losses

  
  top99news - breaking news from the world top newspapers — Authority: 164
  http://www.bbc.co.uk AstraZeneca announces job losses Drugs firm AstraZeneca announces a further 7,300 job cuts over the next two years as part of a new restructuring programme. published date:Thu, 02 Feb 2012 07:45:00 GMT
  13 hours ago

• Pakkausseloste-XYLOCAIN-Lidocaini hydrochloridum monohydricum-AstraZeneca Oy-geeli-2 %-Suomi

  
  myHealthbox — Authority: 122
  Pakkausseloste-XYLOCAIN-Lidocaini hydrochloridum monohydricum-AstraZeneca Oy-geeli-2 %-Suomi http://www.myhealthbox.eu/fi/FI/farmaco/AstraZenecaOy/XYLOCAIN/552226 Nimi XYLOCAIN Maa Suomi Tuottaja AstraZeneca Oy Vaikuttava aine Lidocaini hydrochloridum monohydricum Lääkemuoto geeli ...
  1 day ago

• Market seeks shelter in defensive stocks ahead of EU summit

  
  Business: Market Forces blog | guardian.co.uk — Authority: 115
  Drugmakers and Vodafone rise as investors seek out defensive stocks Pharmaceutical companies GlaxoSmithKline , AstraZeneca and Shire , along with telecoms giant Vodafone were in demand this morning as investors sought out defensive stocks ahead of the EU summit, which gets underway this afternoon (at 2pm). ...
  3 days ago

• The Forward Look, w/c 30 January

  
  The Share Centre Blog — Authority: 121
  Sheridan Admans gives his thoughts on what to expect from companies announcing results in the coming week. Tuesday Babcock (Trading update) The last update painted an improving picture, with an attractive pipeline of potential contracts. Investors will be hoping that this can be rubber stamped, possibly with ...
  1 week ago

• Big Pharma testing waters with mobile tech

  
  FierceBiotech IT — Authority: 411
  Developers of mobile technologies have made some inroads with deep-pocketed drugmakers, which have sought the help of new apps and devices to streamline the development, marketing and sales of meds. Tech and biopharma entrepreneurs are betting that Big Pharma has an appetite for more mobile innovations. With drug ...
  1 week ago

• Up And Down The Ladder… Job Changes

  
  Pharmalot — Authority: 581
  Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them . Don’t be shy. Everyone wants to know who is coming and going, especially with all the ...
  1 week ago

• Pharmalot… Pharmalittle… The Weekend Nears

  
  Pharmalot — Authority: 581
  And so, another working week is about to draw to a close. As you know, this is our signal to daydream about weekend plans. In fact, we already have a list, which includes spending time with our short and not-so-short people, and catching up with some favorite relatives. Oh yes, a few naps are planned, as well. And ...
  1 week ago

• Neuro Drug Focus end of year late-stage results

  
  The Pharmaceutical News — Authority: 99
  Link to this post! Neuro Drug Focus end of year late-stage results " onclick="javascript:this.select()" readonly="readonly" style="width: 100%;" /> The latest post from: The Pharmaceutical News
  2 weeks ago

• Takeda Plans To Cut 2,800 Jobs In US & Europe

  
  Pharmalot — Authority: 581
  Three months after completing its $13 billion acquisition of Nycomed, Takeda Pharmaceuticals now plans to cut roughly 10 percent of its workforce, or 2,800 jobs - about 2,100 from Europe and 700 from the US - by 2016 in order to save approximately $2.6 billion. The reorganization will include closing an unspecified ...
  2 weeks ago

• Researchers Identify Possible Receptor for Key Breast Cancer Regulator

  
  Net News Publisher — Authority: 138
  A key protein potentially involved in regulating breast cancer progression has been identified by researchers at Clarkson University in Potsdam, N.Y. Led by professor Costel Darie, the team worked to identify the binding partner of Tumor Differentiating Factor (TDF), a pituitary hormone that had previously been shown ...
  2 weeks ago

• PARP inhibitors could aid larger ovarian cancer patient population

  
  FierceBiotech Research — Authority: 108
  PARP inhibitors are a promising new class of drugs thought to be an effective weapon against ovarian cancer, among others. But scientists have asserted that no more than 15% of women with the disease--those who have two specific protein mutations--can benefit from the treatment. That may no longer be true. Based on a ...
  2 weeks ago

• (QGEN) Qiagen Expands with New Deals

  
  Stock Blog Hub — Authority: 127
  In an attempt to expand its companion diagnostic portfolio for several types of new anti-cancer... Visit StockBlogHub to view complete post.
  2 weeks ago

• Doc In AstraZeneca Bribe Scandal Commits Suicide

  
  Pharmalot — Authority: 581
  A key figure in a scandal in which AstraZeneca was indicted in Serbia over allegations of offering bribes to physicians has committed suicide. Nenad Borojevic, who was the former director of the Serbian Institute of Oncology and Radiology Nenad Borojevic, was found hanging from a tree in a forest in Belgrade, ...
  2 weeks ago

• Up And Down The Ladder… Job Changes

  
  Pharmalot — Authority: 581
  Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them . Don’t be shy. Everyone wants to know who is coming and going, especially with all the ...
  2 weeks ago

• AstraZeneca taps IMS Health for mining real-world data sources

  
  FierceBiotech IT — Authority: 411
  With a greater burden of proof on drugmakers to get payment for new medicines, London-based pharma AstraZeneca ( $AZN ) has partnered with IMS Health to scour multiple sources of data for real-world evidence on its treatments in Europe. And the companies aim to work together on a specialized research and data analysis ...
  3 weeks ago

• Pharmalot… Pharmalittle… Good Morning

  
  Pharmalot — Authority: 581
  Rise and shine. Another sunny day is on the way. And, of course, that means we will celebrate with a delicious cup of stimulation. We urge you to join us. After all, what better way to prepare for a busy schedule of meetings and deadlines. To help you along, we have gathered a few items of interest. So dig in and ...
  3 weeks ago

Comments about astrazeneca